Studies of the InCise™ Multileaf Collimator (MLC) for the CyberKnife M6™ System Reinforce its Accuracy, Reliability and Precise Dose Delivery SUNNYVALE, Calif. , July 14, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that studies on the clinical use of the CyberKnife ®
SUNNYVALE, Calif. and STOCKHOLM , July 13, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) and RaySearch Laboratories AB (publ) (NASDAQ OMX Stockholm: RAY B) announced today they have signed a long-term collaboration agreement which will allow Accuray to co-market and offer the RayCare ®
10-Year Anniversary of First Total Marrow Irradiation Delivery with the TomoTherapy® System Illustrates Growing Impact of Groundbreaking Approach SUNNYVALE, Calif. , June 9, 2015 /PRNewswire/ -- This month marks the 10-year anniversary of the first successful total marrow irradiation (TMI) using
SUNNYVALE, Calif. , June 2, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its management team is scheduled to present at the Goldman Sachs 36th Annual Global Healthcare Conference in Rancho Palos Verdes, California on Wednesday, June 10, 2015 at 4:00pm PT .
SUNNYVALE, Calif. , May 26, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its management team is scheduled to present at the Jefferies 2015 Healthcare Conference in New York on Wednesday, June 3, 2015 at 2:30pm ET . A live webcast of the presentation will be
SUNNYVALE, Calif. , May 5, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that management is scheduled to present at the Bank of America Merrill Lynch 2015 Healthcare Conference in Las Vegas on Tuesday, May 12, 2015 at 2:20pm PT .
SUNNYVALE, Calif. , April 30, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that it has signed an agreement with MIM Software Inc. to further develop adaptive therapy software for the TomoTherapy ® and CyberKnife ® product portfolios.
SUNNYVALE, Calif. , April 30, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the third fiscal quarter and nine months ended March 31, 2015 . Third Quarter Highlights Gross orders grew 15 percent year-over-year or 21 percent on a constant currency
SUNNYVALE, Calif. , April 23, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the company will highlight new CyberKnife ® and TomoTherapy ® technologies at the European Society for Therapeutic Radiology and Oncology (ESTRO) meeting, booth #2100, in Barcelona, Spain ,
Evaluation of the InCise™ Multileaf Collimator System Successfully Completed SUNNYVALE, Calif. , April 21, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the InCise™ Multileaf Collimator (MLC) for the CyberKnife ® M6™ System will now be available outside the United
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
